Viewing Study NCT00006669


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-02-22 @ 7:24 AM
Study NCT ID: NCT00006669
Status: WITHDRAWN
Last Update Posted: 2021-10-27
First Post: 2000-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
Sponsor: Medstar Health Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View